Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > How is this even possible in this market?

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Apr 22, 2021 10:54am

67 Views

Post# 33044446

RE:RE:RE:RE:How is this even possible in this market?

Bucknelly, you need to use the "Quote" feature so people know which post it is you are referring to.

Bucknelly21 wrote: I thought you were taking a break, as tired as you are with all the complaints I think everyone is equally as tired hearing you say you are taking a break

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia